Attached files
| file | filename |
|---|---|
| 10-K - ALDR-10-K-20171231 - ALDER BIOPHARMACEUTICALS INC | aldr-10k_20171231.htm |
| EX-32.1 - EX-32.1 - ALDER BIOPHARMACEUTICALS INC | aldr-ex321_7.htm |
| EX-31.2 - EX-31.2 - ALDER BIOPHARMACEUTICALS INC | aldr-ex312_9.htm |
| EX-31.1 - EX-31.1 - ALDER BIOPHARMACEUTICALS INC | aldr-ex311_10.htm |
| EX-21.1 - EX-21.1 - ALDER BIOPHARMACEUTICALS INC | aldr-ex211_91.htm |
| EX-10.27 - EX-10.27 - ALDER BIOPHARMACEUTICALS INC | aldr-ex1027_357.htm |
| EX-10.26 - EX-10.26 - ALDER BIOPHARMACEUTICALS INC | aldr-ex1026_356.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-216199) and Form S‑8 (Nos. 333-195807, 333-202738, 333-209663 and 333-216198) of Alder BioPharmaceuticals, Inc., of our report dated February 26, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 26, 2018